Stocks and Investing Stocks and Investing
Thu, March 16, 2017

Matthew Harrison Downgraded (BIIB) to Hold and Decreased Target to $305 on, Mar 16th, 2017


Published on 2024-10-25 20:30:19 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Downgraded "Biogen Inc." (BIIB) to Hold and Decreased Target from $369 to $305 on, Mar 16th, 2017.

Matthew has made no other calls on BIIB in the last 4 months.



There are 2 other peers that have a rating on BIIB. Out of the 2 peers that are also analyzing BIIB, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Alethia Young of "Cantor Fitzgerald" Initiated at Hold and Held Target at $293 on, Friday, December 16th, 2016


This is the rating of the analyst that currently disagrees with Matthew


  • Robyn Karnauskas of "Citigroup" Upgraded from Hold to Strong Buy on, Wednesday, February 8th, 2017

Contributing Sources